Genetic non-syndromic central nervous system malformation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:269550
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Genetic non-syndromic central nervous system (CNS) malformation refers to a broad group of rare congenital structural abnormalities of the brain and/or spinal cord that occur in isolation — meaning they are not part of a recognized syndrome involving multiple organ systems. These malformations arise due to genetic mutations that disrupt normal CNS development during embryogenesis. Unlike syndromic forms, patients do not have the characteristic extra-CNS features (such as facial dysmorphism, skeletal anomalies, or organ malformations) that would point to a specific named syndrome. The central nervous system is the primary organ system affected, and malformations can include abnormalities of cortical development (such as lissencephaly, polymicrogyria, or heterotopia), cerebellar malformations, agenesis or dysgenesis of the corpus callosum, holoprosencephaly spectrum disorders, and neural tube defects, among others. Clinical features vary widely depending on the specific type and severity of the malformation but commonly include intellectual disability, developmental delay, seizures or epilepsy, motor impairment (including spasticity or hypotonia), and in some cases microcephaly or macrocephaly. Neurological deficits may range from mild learning difficulties to severe, life-limiting disability. Diagnosis is typically made through neuroimaging (MRI) and confirmed with genetic testing, which may identify causative mutations in a variety of genes involved in neuronal migration, proliferation, and differentiation. There is currently no curative treatment for genetic non-syndromic CNS malformations. Management is supportive and symptomatic, focusing on seizure control with antiepileptic medications, physical and occupational therapy for motor deficits, speech therapy, and educational support. Neurosurgical intervention may be required in select cases, such as for hydrocephalus or refractory epilepsy. A multidisciplinary approach involving neurologists, geneticists, rehabilitation specialists, and developmental pediatricians is essential for optimizing outcomes and quality of life.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Genetic non-syndromic central nervous system malformation.

View clinical trials →

No actively recruiting trials found for Genetic non-syndromic central nervous system malformation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Genetic non-syndromic central nervous system malformation community →

No specialists are currently listed for Genetic non-syndromic central nervous system malformation.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Genetic non-syndromic central nervous system malformation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Genetic non-syndromic central nervous system malformationForum →

No community posts yet. Be the first to share your experience with Genetic non-syndromic central nervous system malformation.

Start the conversation →

Latest news about Genetic non-syndromic central nervous system malformation

No recent news articles for Genetic non-syndromic central nervous system malformation.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Genetic non-syndromic central nervous system malformation

What is Genetic non-syndromic central nervous system malformation?

Genetic non-syndromic central nervous system (CNS) malformation refers to a broad group of rare congenital structural abnormalities of the brain and/or spinal cord that occur in isolation — meaning they are not part of a recognized syndrome involving multiple organ systems. These malformations arise due to genetic mutations that disrupt normal CNS development during embryogenesis. Unlike syndromic forms, patients do not have the characteristic extra-CNS features (such as facial dysmorphism, skeletal anomalies, or organ malformations) that would point to a specific named syndrome. The central n

At what age does Genetic non-syndromic central nervous system malformation typically begin?

Typical onset of Genetic non-syndromic central nervous system malformation is neonatal. Age of onset can vary across affected individuals.